Cargando…

Drug repurposing for the treatment of glioblastoma multiforme

BACKGROUND: Glioblastoma Multiforme is the deadliest type of brain tumor and is characterized by very poor prognosis with a limited overall survival. Current optimal therapeutic approach has essentially remained unchanged for more than a decade, consisting in maximal surgical resection followed by r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbruzzese, Claudia, Matteoni, Silvia, Signore, Michele, Cardone, Luca, Nath, Kavindra, Glickson, Jerry D., Paggi, Marco G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704391/ https://www.ncbi.nlm.nih.gov/pubmed/29179732 http://dx.doi.org/10.1186/s13046-017-0642-x

Ejemplares similares

Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps
por: Abbruzzese, Claudia, et al.
Publicado: (2020)

Molecular Biology in Glioblastoma Multiforme Treatment
por: Abbruzzese, Claudia, et al.
Publicado: (2022)

Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
por: Persico, Michele, et al.
Publicado: (2022)

The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells
por: Matteoni, Silvia, et al.
Publicado: (2019)

Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro
por: Matteoni, Silvia, et al.
Publicado: (2021)

Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response
por: Matteoni, Silvia, et al.
Publicado: (2021)

The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017)

Biocomputing drug repurposing toward targeted therapies
por: Cardone, Luca
Publicado: (2016)

Drug repurposing against COVID-19: focus on anticancer agents
por: Ciliberto, Gennaro, et al.
Publicado: (2020)

SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells
por: Talarico, Cristina, et al.
Publicado: (2016)

Neurocytological Advances in the Treatment of Glioblastoma Multiforme
por: Fiani, Brian, et al.
Publicado: (2021)

Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme
por: Nam, L., et al.
Publicado: (2018)

Drug target ranking for glioblastoma multiforme
por: Saraf, Radhika, et al.
Publicado: (2021)

Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice
por: Nath, Kavindra, et al.
Publicado: (2016)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Boosting the arsenal against COVID-19 through computational drug repurposing
por: Ciliberto, Gennaro, et al.
Publicado: (2020)

pH-dependent structural characteristics of lonidamine: (1)H and (13)C NMR study
por: Gupta, Pradeep Kumar, et al.
Publicado: (2023)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

Emerging treatment strategies for glioblastoma multiforme
por: Carlsson, Steven K, et al.
Publicado: (2014)

Glioblastoma multiforme: Diagnosis, treatment, and invasion
por: Li, Jiawei, et al.
Publicado: (2023)

Reassessing the Role of Intra-Arterial Drug Delivery for Glioblastoma Multiforme Treatment
por: Ellis, Jason A., et al.
Publicado: (2015)

Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art
por: Di Filippo, Leonardo Delello, et al.
Publicado: (2021)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme
por: Lim, Xin Yuan, et al.
Publicado: (2023)

Current and Future Novel Treatments for Glioblastoma Multiforme
por: Tyler, Betty, et al.
Publicado: (2014)

Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme
por: Lubanska, Dorota, et al.
Publicado: (2017)

Radiation and concomitant chemotherapy for patients with glioblastoma multiforme
por: Villà, Salvador, et al.
Publicado: (2014)

Metabolic modeling-based drug repurposing in Glioblastoma
por: Tomi-Andrino, Claudio, et al.
Publicado: (2022)

Current Perspective on the Natural Compounds and Drug Delivery Techniques in Glioblastoma Multiforme
por: Behl, Tapan, et al.
Publicado: (2021)

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
por: Pearson, Joshua R. D., et al.
Publicado: (2020)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u9v0t5iqptrgagcrkkh91dnupq